23 Jun 2017 | 1:03 AM
 

Nectar Lifesciences Ltd. Share Price Live (BSE)
0

BSE Code: 532649 | NSE Symbol: NECLIFE
33.75
0.25
(0.75 %)
22 Jun 2017 | 04:00 PM
Change company
  • Open (Rs)
    33.65
  • Prev. close (Rs.)
    33.50
  • High (Rs.)
    34.25
  • Low (Rs.)
    33.65
  • 52W H (Rs.)
    43.65
  • 52W L (Rs.)
    28.55
  • Volume (Rs.)
    48070
  • MCap (Rs in Cr.)
    601.64
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
2.64
Operating Margin (%)
16.38
Gross Profit Margin (%)
11.29
Net Profit Margin (%)
3.53
Total Debt/Equity
0.86
Dividend payout Ratio (Net Profit)
4.56
Earning Retention Ratio
95.44

News

23 Aug 2016 - 17:28:00-Pharma major Nectar Lifesciences Ltd on Tuesday reported a drop of 16...
29 Dec 2015 - 13:07:00-Pharma major Nectar Lifesciences Ltd on Tuesday said it’s Board of Directors has appointed Gul...
17 Dec 2015 - 09:54:00-Leading pharma company Nectar Lifesciences has said that it has been honored with the coveted Nation...
15 May 2015 - 13:13:00-Pharma major Nectar Lifesciences Ltd on Friday said it has received ANVISA cGMP (Current Good Manufa...

Announcements

21-Jun-2017
Nectar Lifesciences - Notice Of Adjourned Board Meeting To Be Held On June 27 2017.
31-May-2017
Nectar Lifesciences Ltd. - Dividend Updates
30-May-2017
Nectar Lifesciences - Outcome of Board Meeting
23-May-2017
Nectar Lifesciences - Board to consider Final Dividend
23-May-2017
Nectar Lifesciences - Notice Of Board Meeting Meeting To Be Held On May 30 2017 To Consider Audited Financial Results For Th

Religare Research

22 Jun 2017 | 10:20 AM
• Gold lingered near 5-week low • Oil slipped, headed for weakest first half in two decades • Coppe...
22 Jun 2017 | 10:10 AM
The Indian rupee settled largely unchanged against the dollar, as foreign inflows offset earlier los...
22 Jun 2017 | 10:10 AM
The Indian rupee settled largely unchanged against the dollar, as foreign inflows offset earlier los...
22 Jun 2017 | 07:00 AM
Indications are in the favor of further consolidation but stock specific move will continue.

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors55.80%
Mutual Funds/UTI0.00%
FI/Banks0.83%
Insurance0.83%
FII3.39%
Government0.00%
Others22.83%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,388.00(-0.43)
3578
 Kovai Medical Center and Hospital Ltd.
1,239.90(0.40)
11816
 Merck Ltd.
1,100.90(-0.19)
3302
 AstraZeneca Pharma India Ltd.
917.60(-0.98)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Nectar Lifesciences Ltd.-2.15-1.700.15
NIFTY(S&P CNX)191.75599.551,650.90
BSE SENSEX719.772,123.065,311.14
BSE 500299.34949.392,533.52

Corporate Details

Key Personal
Dinesh Dua
Director & CEO
Harprakash Singh Gill
President & Director
Rima Marphatia
Nominee Director
Key Address
Registered Office
Village Saidpura Tehsil Derabassi Distt. S.A.S. Nagar,Mohali,Punjab

Tel:01762-308000 308001, Fax:01762-281187 308135

sunderlal@neclife.com
http://www.neclife.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Nectar Lifesciences Ltd. that will help you decide whether to buy, sell or hold Nectar Lifesciences Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Nectar Lifesciences Ltd.